equityflowunderstand the flow and follow it
EquityFlowCompanies › MultivisionDx

MultivisionDx

Healthtech · Helsinki, FI

Spatial biology AI platform that creates tumor 'fingerprints' to predict response to therapies.

Funding history

DateRoundAmount
Dec 2025Pre Seed
Helsinki-based MultivisionDx, a University of Helsinki spinout, raised a 1 million euro pre-seed led by Antler for AI-based precision cancer diagnostics.
$1.2M

Investors

Tap an investor to see what else they have backed.

Other companies in Healthtech

Other companies in FI

Other companies at Pre Seed stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.